Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TAK and other ETFs, options, and stocks.

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business divisions: Gastrointestinal Diseases, Rare Diseases, Plasma-Derived Therapies, Oncology, Vaccines, and Neuroscience The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. 

CEO
Christophe Weber
CEOChristophe Weber
Employees
47,455
Employees47,455
Headquarters
Osaka, Osaka
HeadquartersOsaka, Osaka
Founded
1781
Founded1781
Employees
47,455
Employees47,455

TAK Key Statistics

Market cap
57.19B
Market cap57.19B
Price-Earnings ratio
74.50
Price-Earnings ratio74.50
Dividend yield
3.24%
Dividend yield3.24%
Average volume
3.37M
Average volume3.37M
High today
$18.25
High today$18.25
Low today
$18.06
Low today$18.06
Open price
$18.17
Open price$18.17
Volume
2.68M
Volume2.68M
52 Week high
$18.90
52 Week high$18.90
52 Week low
$12.99
52 Week low$12.99

TAK News

TipRanks 13h
Takeda Updates Early-Stage Multiple Myeloma Study for TAK-079, Signaling Ongoing Oncology Push

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter,...

TipRanks 3d
Takeda upgraded to Outperform from Market Perform at Bernstein

Bernstein upgraded Takeda (TAK) to Outperform from Market Perform with a price target of 6,900 yen, up from 5,100 yen, citing “bold” cost cuts and multiple upco...

Simply Wall St 3d
Takeda’s R&D Shakeup And Leadership Transition Might Change The Case For Investing In Takeda Pharmaceutical - simplywall.st

...

Takeda’s R&D Shakeup And Leadership Transition Might Change The Case For Investing In Takeda Pharmaceutical - simplywall.st

Analyst ratings

60%

of 15 ratings
Buy
60%
Hold
33.3%
Sell
6.7%

More TAK News

Benzinga 5d
Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's Why

Takeda Ends Drug Partnership For Strategic Reasons Takeda on Friday notified Denali Therapeutics regarding the termination of their collaboration agreement to...

Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's Why

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.